Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125394681	12539468	1	I	20160621	20160627	20160708	20160708	EXP	IT-MINISAL02-365019	IT-TEVA-673206ACC	TEVA		65.33	YR		M	Y	76.00000	KG	20160708		MD	IT	IT

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125394681	12539468	1	PS	CISPLATINO TEVA ITALIA	CISPLATIN	1	Intravenous (not otherwise specified)				Y				74656	135	MG	SOLUTION FOR INFUSION
125394681	12539468	2	SS	NAVELBINE	VINORELBINE TARTRATE	1	Intravenous (not otherwise specified)				Y				0	45	MG	SOLUTION FOR INFUSION

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125394681	12539468	1	Lung adenocarcinoma
125394681	12539468	2	Lung adenocarcinoma

Outcome of event

Event ID	CASEID	OUTC COD
125394681	12539468	HO

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
125394681	12539468		Diarrhoea
125394681	12539468		Rectal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125394681	12539468	1	20160615	20160615	0
125394681	12539468	2	20160615	20160615	0